The Swedish speciality pharmaceutical company, Pharmalink AB, has raised SEK35 million (€3.93 million) in a share placement with its existing investors including Sweden’s Industrifonden, to support the late-stage development of two products. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
